Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
16.58
-0.14 (-0.84%)
Jun 1, 2026, 1:09 PM EDT - Market open
Caris Life Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 907.29 | 812.03 | 412.26 | 306.13 | 258.49 | |
Revenue Growth (YoY) | 100.51% | 96.97% | 34.67% | 18.43% | - |
Cost of Revenue | 283.84 | 272.87 | 233.48 | 216.82 | 178.46 |
Gross Profit | 623.45 | 539.17 | 178.78 | 89.31 | 80.02 |
Selling, General & Admin | 405.28 | 392.47 | 321.99 | 291.98 | 294.51 |
Research & Development | 109.83 | 101.58 | 113.92 | 116.88 | 101.27 |
Total Operating Expenses | 515.11 | 494.06 | 435.9 | 408.86 | 395.78 |
Operating Income | 108.35 | 45.11 | -257.12 | -319.55 | -315.76 |
Interest Income | 22.83 | 16.5 | 7.12 | 11.26 | 0.95 |
Interest Expense | -56.88 | -56.85 | -50.03 | -31.61 | -26.68 |
Other Non-Operating Income (Expense) | -40.45 | -72.85 | 18.14 | -1.51 | 20.66 |
Total Non-Operating Income (Expense) | -74.5 | -113.2 | -24.77 | -21.86 | -5.07 |
Pretax Income | 33.85 | -68.09 | -281.89 | -341.42 | -320.83 |
Provision for Income Taxes | 0.13 | - | - | - | - |
Net Income | -1.02 | -68.09 | -378.26 | -462.53 | -320.83 |
Net Income Attributable to Preferred Dividends | - | - | 96.37 | 121.11 | - |
Net Income to Common | -1.02 | -68.09 | -378.26 | -462.53 | -320.83 |
Shares Outstanding (Basic) | 228 | 167 | 35 | 35 | 0 |
Shares Outstanding (Diluted) | 235 | 167 | 35 | 35 | 0 |
Shares Change (YoY) | 560.35% | 371.04% | 1.59% | 104626.10% | - |
EPS (Basic) | -7.59 | -3.22 | -10.66 | -13.24 | -12.00 |
EPS (Diluted) | -7.61 | -3.22 | -10.66 | -13.24 | -12.00 |
Shares Outstanding | 282.65 | 282.53 | 35.63 | 36.27 | 35.65 |
Free Cash Flow | 123.46 | 66.9 | -253.64 | -298.42 | -327.96 |
Free Cash Flow Growth | 84.55% | - | - | - | - |
Free Cash Flow Per Share | 0.52 | 0.40 | -7.15 | -8.54 | -9829.27 |
Gross Margin | 68.72% | 66.40% | 43.37% | 29.17% | 30.96% |
Operating Margin | 11.94% | 5.56% | -62.37% | -104.38% | -122.16% |
Profit Margin | -7.97% | -8.38% | -68.38% | -111.53% | -124.12% |
FCF Margin | 13.61% | 8.24% | -61.52% | -97.48% | -126.88% |
EBITDA | 128.98 | 67.73 | -208.21 | -270.55 | -267.5 |
EBITDA Margin | 14.22% | 8.34% | -50.50% | -88.38% | -103.49% |
EBIT | 108.35 | 45.11 | -257.12 | -319.55 | -315.76 |
EBIT Margin | 11.94% | 5.56% | -62.37% | -104.38% | -122.16% |
Effective Tax Rate | 0.40% | 0.00% | 0.00% | 0.00% | 0.00% |